投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
3.1 %
年文章数
1297
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Clinical Lung Cancer is the world’s premier peer-reviewed, tumor-specific, clinical oncology devoted to publishing clinically relevant articles on detection, diagnosis, prevention, and treatment of lung cancer. Indexed in Index Medicus/Medline/Pubmed, ISI (Current Contents/Clinical Medicine, Science Citation Index Expanded (Web of Science), Journal Citation Reports), EMBASE, CINAHL, and Chemical Abstracts. Each issue of Clinical Lung Cancer features peer–reviewed original contributions‚ invited comprehensive reviews‚ and current treatment reports‚ as well as "Meeting Highlights" reports taken from major oncology meetings each year. Also included are brief editorials of current news and the latest topics concerning lung cancer for the clinician.
